Manufacturer record
Alexa Phamaceuticals: regulatory record
Last checked 3 November 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
2 batches manufactured by Alexa Phamaceuticals (Himachal Pradesh) were declared Not of Standard Quality in September 2026. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Most recent flagged batch: ABT25719, Amoxycillin and Potassium Clavulanate Tablets IP (exp Jul 2027). LUCKNOW, Uttar Pradesh (state lab) found it not of standard quality: The sample does not conform to IP with respect to content of Amoxycillin & Clavulanic acid on the basis of tests done. Listed in the September 2026 alert.
Records by type
2 records linked to Alexa Phamaceuticals in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches per year
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| Amoxycillin and Potassium Clavulanate Tablets IP | Batch ABT25719Mfg Feb 2026 · Exp Jul 2027 | The sample does not conform to IP with respect to content of Amoxycillin & Clavulanic acid on the basis of tests doneOther | LUCKNOW, Uttar PradeshState lab | Sep 2026 |
| Amoxycillin & Potassium Clavulanate Tablets | Batch ABT26059Mfg Apr 2026 · Exp Sep 2027 | The sample does not conform to IP in respect of Identification of Clavulanic Acid, hence spurious and the sampledoes not conform to I.P., in respect of Assay of Amoxycillin.Assay | LUCKNOW, Uttar PradeshState lab | Sep 2026 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.